BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Debom GN, Rubenich DS, Braganhol E. Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes. Front Neurosci 2021;15:648476. [PMID: 35069091 DOI: 10.3389/fnins.2021.648476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gelsleichter NE, Azambuja JH, Rubenich DS, Braganhol E. CD73 in glioblastoma: Where are we now and what are the future directions? Immunol Lett 2023:S0165-2478(23)00040-8. [PMID: 36958430 DOI: 10.1016/j.imlet.2023.03.005] [Reference Citation Analysis]
2 Barnes DA, Hoener MC, Moore CS, Berry MD. TAAR1 Regulates Purinergic-induced TNF Secretion from Peripheral, But Not CNS-resident, Macrophages. J Neuroimmune Pharmacol 2022. [DOI: 10.1007/s11481-022-10053-8] [Reference Citation Analysis]
3 Huang Q, Chen L, Liang J, Huang Q, Sun H. Neurotransmitters: Potential Targets in Glioblastoma. Cancers 2022;14:3970. [DOI: 10.3390/cancers14163970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ferrari D, Gessi S, Merighi S, Nigro M, Travagli A, Burns JS. Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling. Front Cell Dev Biol 2022;10:893709. [DOI: 10.3389/fcell.2022.893709] [Reference Citation Analysis]